This finding is consistent with our observation of a substantially higher frequency of the T allele (50%) in the discovery cohort and (36%) in our validation cohort and supports a possible role of ABCC8 variants in obesity-associated MASLD pathogenesis. This evidence concerns the gene ABCC8 and metabolic dysfunction-associated steatotic liver disease.